Platform Technology Partners’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$245K Sell
1,136
-65
-5% -$12.4K 0.04% 313
2026
Q1
$220K Buy
+1,201
New +$221K 0.04% 299
2024
Q4
Sell
-1,403
Closed -$272K 219
2024
Q3
$272K Sell
1,403
-19
-1% -$3.98K 0.09% 186
2024
Q2
$330K Buy
+1,422
New +$309K 0.11% 157
2023
Q4
$315K Hold
1,289
0.12% 154
2023
Q3
$331K Hold
1,289
0.16% 135
2023
Q2
$361K Buy
1,289
+5
+0.4% +$1.49K 0.17% 130
2023
Q1
$357K Sell
1,284
-17
-1% -$4.7K 0.18% 132
2022
Q4
$360K Sell
1,301
-14
-1% -$3.95K 0.19% 125
2022
Q3
$351K Hold
1,315
0.2% 118
2022
Q2
$268K Hold
1,315
0.15% 147
2022
Q1
$277K Sell
1,315
-12
-0.9% -$2.61K 0.13% 150
2021
Q4
$318K Sell
1,327
-159
-11% -$40.9K 0.14% 159
2021
Q3
$421K Hold
1,486
0.19% 136
2021
Q2
$515K Buy
+1,486
New +$450K 0.21% 125
2020
Q4
$293K Sell
1,196
-19
-2% -$4.9K 0.14% 154
2020
Q3
$345K Buy
1,215
+1
+0.1% +$279 0.21% 120
2020
Q2
$325K Sell
1,214
-67
-5% -$20.1K 0.23% 122
2020
Q1
$405K Sell
1,281
-121
-9% -$36.7K 0.37% 81
2019
Q4
$416K Buy
+1,402
New +$389K 0.31% 100

Other funds holding BIIB

Platform Technology Partners's BIIB Position: Q2 2026 in Review

Platform Technology Partners reduced its Biogen (BIIB) stake by 5.4% in Q2 2026, selling an estimated $12.4K and leaving 1,136 shares worth $245K. The position accounts for 0.04% of the portfolio, ranked #313.

Platform Technology Partners first reported a position in BIIB in Q4 2019 and has held it in 20 quarters since. The position peaked at $515K in Q2 2021. 1,043 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Platform Technology Partners held 1,136 shares of Biogen worth $245K as of Q2 2026.
  • Platform Technology Partners sold 65 Biogen shares in Q2 2026, an estimated $12.4K.
  • Biogen made up 0.04% of Platform Technology Partners's portfolio in Q2 2026, its #313 holding.
  • Platform Technology Partners first reported a position in Biogen in Q4 2019 and has held it in 20 quarters since.
  • Platform Technology Partners's Biogen position peaked at $515K in Q2 2021.
  • 1,043 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Platform Technology Partners's 13F filing for Q2 2026, filed 24 Jul 2026.